FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.
about
Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in CancerGastric cancer: The times they are a-changin'Prognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System ReviewFOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patientsNID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cellsFOXM1 promotes invasion and migration of colorectal cancer cells partially dependent on HSPA5 transactivationSolanum Incanum Extract Downregulates Aldehyde Dehydrogenase 1-Mediated Stemness and Inhibits Tumor Formation in Ovarian Cancer Cells.Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells.Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinomaGenetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway.Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis.Small putative NANOG, SOX2, and SSEA-4-positive stem cells resembling very small embryonic-like stem cells in sections of ovarian tissue in patients with ovarian cancerFOXM1 is a therapeutic target for high-risk multiple myeloma.HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes.Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signalingOTUB1-catalyzed deubiquitination of FOXM1 facilitates tumor progression and predicts a poor prognosis in ovarian cancer.FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop.Cadherins Associate with Distinct Stem Cell-Related Transcription Factors to Coordinate the Maintenance of Stemness in Triple-Negative Breast Cancer.Plk1 Regulates the Repressor Function of FoxM1b by inhibiting its Interaction with the Retinoblastoma ProteinThe FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells.GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancerA Feedback Loop Between miR-30a/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells.NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.MicroRNA-134 reverses multidrug resistance in human lung adenocarcinoma cells by targeting FOXM1Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cellsThe relationship between platinum drug resistance and epithelial-mesenchymal transition.Increased FoxM1 expression is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma.Epithelial-to-Mesenchymal Transition in the Pathogenesis and Therapy of Head and Neck CancerSIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells.VSV based virotherapy in ovarian cancer: the past, the present and …future?Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.FOXM1 and FOXQ1 Are Promising Prognostic Biomarkers and Novel Targets of Tumor-Suppressive miR-342 in Human Colorectal Cancer.Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death.Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer.Acquisition of EGFR TKI resistance and EMT phenotype is linked with activation of IGF1R/NF-κB pathway in EGFR-mutant NSCLC.Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.Activation of TWIST1 by COL11A1 promotes chemoresistance and inhibits apoptosis in ovarian cancer cells by modulating NF-κB-mediated IKKβ expression.Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.
P2860
Q26741846-1032CFDC-1C52-42FD-A672-7889B8DA2826Q26776195-4518BA84-1C0E-447C-A29A-7FF298AE40E8Q26785676-7BA5D19E-AD3E-4099-A580-D6EA20E0E68BQ33651605-F053C6EF-E8A5-466D-83FC-4899200F4C64Q33779379-833B89A5-7A8B-42A2-AE43-237AC0465CF3Q35976142-99490F35-574A-42B7-AD99-590052F40B02Q36048518-D3602A72-8FF0-464E-91CB-5EEB900C216DQ36293810-63911124-81E7-451D-8F7C-EE16738FC983Q36413366-45EF3A4A-EBEA-4E52-8FB3-DE00F0C168FFQ36413849-C7265570-248D-4290-BAF3-43BF5206D955Q36545318-D0897631-509A-4D68-8738-1C96C209B001Q36562209-7C27CB0C-0712-4F30-8242-66B2FD9E61FDQ36610848-7DB50449-9349-483A-8D7F-24D123E67D76Q36651828-B04724F2-4CDD-4718-9EAC-2C040CC676D8Q36783627-57F33FB8-9F10-421A-9BAD-3CAFCE81FCF6Q37176592-D7DB240E-9CA7-4C42-8B63-95B21E21F80BQ37257711-E122FDE7-7D06-4C0A-A7D1-6AC0793505DBQ37392807-B43E11E0-62D6-4A5B-9A7C-995B5189DEA9Q37644850-9D7FFF10-8DCC-4E79-94E5-9A85201AD7B4Q37723691-E5B71E30-75AC-4CD6-BC3E-BEA402CC53CCQ37741081-DC892354-665D-4739-815E-4E6FFE4A60C4Q37745486-1BC42CD8-968D-4B77-A37E-F8B5BB3837BFQ37747417-1C043E96-7C9F-453D-B575-909B1CAC9C11Q38715514-FC8397C5-F1D6-4D44-B55E-B88E8CF8B813Q38800311-08EEB390-EE63-4606-BB74-9AF2411A28EEQ38814178-9A07EDF0-3C44-4C9E-8053-A3F533B6D446Q38862527-2AB7AF14-D5C8-4AB4-B9EB-70298B7076B8Q39061847-A0C86F7D-39AA-41C6-A363-EFD2B264C7AAQ39077208-6F2D43C3-BAEC-4C67-9ACA-7FA4C2D7AD61Q39411041-3D30B156-7251-4483-8667-837210695E38Q39991261-32FB5833-5E85-45D6-8B06-3CE7DDCC5F7DQ41441101-004F1DA5-E965-4161-A323-C648F40EFF57Q41552639-8036E9AF-8FF1-4D5C-B492-1E86B8DC6CC9Q41637392-7E439595-31A7-43F0-818F-F657664EC163Q41698570-C0A50C96-8EF4-4C7E-99DF-CD74ED438F64Q42317503-D39C6F63-8CB7-466A-8BD5-087F05A8C4F0Q47119773-447446A5-E8B5-421F-A017-23E32767F622Q47140422-8DB2323E-D69C-4ADB-A01C-1BF4117FE03EQ47942760-FA5E7BF9-8CB2-49FA-A224-7F353C42DBB6Q48124146-DD891244-8FF2-4871-A1AD-31D4E066A368
P2860
FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
FOXM1 confers to epithelial-me ...... elial ovarian carcinoma cells.
@ast
FOXM1 confers to epithelial-me ...... elial ovarian carcinoma cells.
@en
type
label
FOXM1 confers to epithelial-me ...... elial ovarian carcinoma cells.
@ast
FOXM1 confers to epithelial-me ...... elial ovarian carcinoma cells.
@en
prefLabel
FOXM1 confers to epithelial-me ...... elial ovarian carcinoma cells.
@ast
FOXM1 confers to epithelial-me ...... elial ovarian carcinoma cells.
@en
P2093
P2860
P356
P1433
P1476
FOXM1 confers to epithelial-me ...... helial ovarian carcinoma cells
@en
P2093
Chang-Hwa Chang
Cheng-Yang Chou
Huei-Yu Tsai
Keng-Fu Hsu
Soon-Cen Huang
Wen-Tai Chiu
Yu-Fang Huang
P2860
P304
P356
10.18632/ONCOTARGET.2957
P407
P577
2015-02-01T00:00:00Z